MedPath

Role of Sentinel Lymph Node in Early Stage Ovarian Cancer

Phase 2
Completed
Conditions
Health Condition 1: C569- Malignant neoplasm of unspecifiedovaryHealth Condition 2: O- Medical and Surgical
Registration Number
CTRI/2022/06/043275
Lead Sponsor
AIIMS Rishikesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
29
Inclusion Criteria

Patients with stage I and II epithelial ovarian cancers

Patients with suspicious ovarian masses planned for hysterectomy and or salpingo-oophorectomy

Exclusion Criteria

Signs of malignant spread to the abdominal cavity on pre-operative imaging

Patients with allergies to the tracers

Diagnosed with malignancy other than ovarian cancer

Prior history of pelvic or para-aortic lymphadenectomy or lymph node sampling

Suspicious lymph nodal involvement on imaging

Pregnant or lactating patients

Not willing to participate in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath